Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. E. Ammatuna

Publicaties

Acute promyelocytic leukaemia in low-income and middle-income countries: a Brazilian experience

Beyond The Skin: B Cells in Pemphigus Vulgaris, Tolerance and Treatment

Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry

The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey

VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia

Lees meer